Novartis lifts guidance again as demand climbs for top drugs

Novartis has boosted its 2024 outlook for a second time this year, thanks to strong sales for some of its biggest drugs used to treat heart failure and other ailments.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnNovartis has boosted its 2024 outlook for a second time this year, thanks to strong sales for some of its biggest drugs used to treat heart failure and other ailments.nnDiscussion:nn” ai_name=”